PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9682221-4	1998	The levels of MAo and B were assayed: MAO A showed a K(m) of 137.1 +/- 16.2 microM and a V(m) of 10.4 +/- 2.5 nmol mg-1 min-1 for serotonin; MAo B had a K(m) of 9.9 +/- 1.6 microM and V(m) of 4.3 +/- 1.1 nmol mg-1 min-1 for beta-phenylethylamine (mean +/- SE of seven hearts).	phenethylamine	224-245	monoamine oxidase A	Homo sapiens	38-43	
20227955-0	1980	Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?	phenethylamine	0-21	monoamine oxidase A	Homo sapiens	62-81	
23858446-2	2013	The combined deficiency of MAO A and B results in significantly elevated levels of serotonin (5-hydroxytryptamine), norepinephrine, dopamine, and beta-phenylethylamine; in humans and mice, these neurochemical changes are accompanied by neurodevelopmental perturbations as well as autistic-like responses.	phenethylamine	146-167	monoamine oxidase A	Homo sapiens	27-38	
20073575-7	2010	As shown by enzyme assays using [14C]serotonin or [14C]beta-phenylethylamine as selective MAO-A or MAO-B substrates, MAO-A is largely predominant in MSCs.	phenethylamine	55-76	monoamine oxidase A	Homo sapiens	90-95	
20073575-7	2010	As shown by enzyme assays using [14C]serotonin or [14C]beta-phenylethylamine as selective MAO-A or MAO-B substrates, MAO-A is largely predominant in MSCs.	phenethylamine	55-76	monoamine oxidase A	Homo sapiens	117-122	
14628189-4	2003	Inhibition of monoamine-oxidase type B (MAO-B) and monoamine oxidase type A (MAO-A) activity was determined by measurement of as beta-phenylethylamine (PEA) by GCMS and 5-hydroxyindoleacetic acid (5-HIAA) by High Performance Liquid Chromatography (HPLC) assays.	phenethylamine	129-150	monoamine oxidase A	Homo sapiens	51-75	
14628189-4	2003	Inhibition of monoamine-oxidase type B (MAO-B) and monoamine oxidase type A (MAO-A) activity was determined by measurement of as beta-phenylethylamine (PEA) by GCMS and 5-hydroxyindoleacetic acid (5-HIAA) by High Performance Liquid Chromatography (HPLC) assays.	phenethylamine	129-150	monoamine oxidase A	Homo sapiens	77-82	
14628189-4	2003	Inhibition of monoamine-oxidase type B (MAO-B) and monoamine oxidase type A (MAO-A) activity was determined by measurement of as beta-phenylethylamine (PEA) by GCMS and 5-hydroxyindoleacetic acid (5-HIAA) by High Performance Liquid Chromatography (HPLC) assays.	phenethylamine	152-155	monoamine oxidase A	Homo sapiens	51-75	
14628189-4	2003	Inhibition of monoamine-oxidase type B (MAO-B) and monoamine oxidase type A (MAO-A) activity was determined by measurement of as beta-phenylethylamine (PEA) by GCMS and 5-hydroxyindoleacetic acid (5-HIAA) by High Performance Liquid Chromatography (HPLC) assays.	phenethylamine	152-155	monoamine oxidase A	Homo sapiens	77-82	
11134050-5	2001	Mutant MAO A-I335Y became like MAO B, which exhibits a higher preference for beta-phenylethylamine than for the MAO A preferred substrate serotonin (5-hydroxytryptamine), and became more sensitive to deprenyl (MAO B-specific inhibitor) than to clorgyline (MAO A-specific inhibitor).	phenethylamine	77-98	monoamine oxidase A	Homo sapiens	7-12	
11106506-0	2000	Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A.	phenethylamine	49-63	monoamine oxidase A	Homo sapiens	101-120	
11106506-1	2000	The interaction of recombinant human liver monoamine oxidase A (MAO A) with a series of phenethylamine substrate analogues has been investigated by steady-state and stopped-flow kinetic techniques.	phenethylamine	88-102	monoamine oxidase A	Homo sapiens	43-62	
11106506-1	2000	The interaction of recombinant human liver monoamine oxidase A (MAO A) with a series of phenethylamine substrate analogues has been investigated by steady-state and stopped-flow kinetic techniques.	phenethylamine	88-102	monoamine oxidase A	Homo sapiens	64-69	
11106506-5	2000	Phenethylamine oxidation by MAO A can be described as the C-H bond cleavage step being rate limiting in catalysis and with oxygen reacting with the reduced enzyme-imine complex.	phenethylamine	0-14	monoamine oxidase A	Homo sapiens	28-33	
11106506-7	2000	The binding affinities of a series of para-substituted phenethylamine analogues to MAO A show an increase in affinity of the deprotonated amine with increasing van der Waals volume of the substituent.	phenethylamine	55-69	monoamine oxidase A	Homo sapiens	83-88	
2924086-4	1989	The results demonstrated the presence of MAO A and B in human thyroid cells which oxidized 5-hydroxytryptamine and 2-phenylethylamine, respectively, and were selectively inhibited by the MAO inhibitors clorgyline and (-)-deprenyl.	phenethylamine	115-133	monoamine oxidase A	Homo sapiens	41-52	
2622533-3	1989	While dopaminergic neurons of the substantia nigra revealed no staining for monoamine oxidase, noradrenergic neurons of the locus coeruleus stained positively with the monoamine oxidase-A substrate serotonin, and serotonergic neurons of the raphe nuclei were stained by the monoamine oxidase-B substrate beta-phenylethylamine.	phenethylamine	304-325	monoamine oxidase A	Homo sapiens	168-187	
3928010-2	1985	Both selective MAO-A and MAO-B inhibitors markedly potentiated nictitating membrane contractions in response to beta-phenylethylamine (PEA).	phenethylamine	112-133	monoamine oxidase A	Homo sapiens	15-20	
3928010-2	1985	Both selective MAO-A and MAO-B inhibitors markedly potentiated nictitating membrane contractions in response to beta-phenylethylamine (PEA).	phenethylamine	135-138	monoamine oxidase A	Homo sapiens	15-20	
25253656-0	2014	Profiling substrate specificity of two series of phenethylamine analogs at monoamine oxidase A and B.	phenethylamine	49-63	monoamine oxidase A	Homo sapiens	75-100	
25253656-3	2014	In this study we present a systematic study of the MAO-A and MAO-B substrate specificity profile by probing two series of phenethylamine analogs.	phenethylamine	122-136	monoamine oxidase A	Homo sapiens	51-56	
11812236-7	2002	The steady-state kinetic properties of P. pastoris-expressed MAO-A are similar to those of S. cerevisiae-expressed MAO-A using the following substrates: phenethylamine, p-CF(3)-benzylamine, dopamine, serotonin, and kynuramine.	phenethylamine	153-167	monoamine oxidase A	Homo sapiens	61-66	
11812236-7	2002	The steady-state kinetic properties of P. pastoris-expressed MAO-A are similar to those of S. cerevisiae-expressed MAO-A using the following substrates: phenethylamine, p-CF(3)-benzylamine, dopamine, serotonin, and kynuramine.	phenethylamine	153-167	monoamine oxidase A	Homo sapiens	115-120	
10936214-3	2000	When compared with MAO A, MAO A-F208I showed a sixfold decrease in the specificity constant k(cat)/K(m) for both the MAO A- and the MAO B-preferring substrates 5-hydroxytryptamine and beta-phenylethylamine, respectively.	phenethylamine	184-205	monoamine oxidase A	Homo sapiens	26-31	
10936214-3	2000	When compared with MAO A, MAO A-F208I showed a sixfold decrease in the specificity constant k(cat)/K(m) for both the MAO A- and the MAO B-preferring substrates 5-hydroxytryptamine and beta-phenylethylamine, respectively.	phenethylamine	184-205	monoamine oxidase A	Homo sapiens	26-31	
9503561-4	1997	MAO-A preferentially deaminates serotonin (5HT) and is selectively inhibited by harmine and clorgyline, while MAO-B preferentially deaminates phenethylamine and benzylamine, and is selectively inhibited by (-)deprenyl as well as low concentrations of pargyline.	phenethylamine	142-156	monoamine oxidase A	Homo sapiens	0-5	
1759390-7	1991	In deprenyl pretreated mitochondria the potency of MAO-A-dependent effects of these amines was: serotonin greater than tyramine much greater than much greater than 2-phenylethylamine.	phenethylamine	164-182	monoamine oxidase A	Homo sapiens	51-56